世界のコデイン系麻酔剤市場予測（～2028年）：単体コデイン、多成分薬物

• 英文タイトル：Global Codeine Narcotic Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8770 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

コデイン系麻酔剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のコデイン系麻酔剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 コデイン系麻酔剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・単体コデイン、多成分薬物 用途別セグメントは次のように区分されます。 ・麻薬性鎮痛薬、鎮咳薬、その他 世界のコデイン系麻酔剤市場の主要な市場プレーヤーは以下のとおりです。 ・Taiji、Mallinckrodt、TEVA、Johnson & Johnson、Medreich、Sanofi Aventis、Cipla、Hikma、Pharmaceutical Associates、Novartis、Apotex、Mylan、Aristo Pharma GmbH、Lannett Company、Laboratoire Riva 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、コデイン系麻酔剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なコデイン系麻酔剤メーカーの企業概要、2019年～2022年までのコデイン系麻酔剤の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なコデイン系麻酔剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別コデイン系麻酔剤の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのコデイン系麻酔剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのコデイン系麻酔剤市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびコデイン系麻酔剤の産業チェーンを掲載しています。 ・第13、14、15章では、コデイン系麻酔剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Taiji、Mallinckrodt、TEVA、Johnson & Johnson、Medreich、Sanofi Aventis、Cipla、Hikma、Pharmaceutical Associates、Novartis、Apotex、Mylan、Aristo Pharma GmbH、Lannett Company、Laboratoire Riva ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：単体コデイン、多成分薬物 ・用途別分析2017年-2028年：麻薬性鎮痛薬、鎮咳薬、その他 ・コデイン系麻酔剤の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・コデイン系麻酔剤のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・コデイン系麻酔剤のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・コデイン系麻酔剤の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・コデイン系麻酔剤の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Codeine Narcotic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Codeine Narcotic market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Narcotic Analgesic accounting for % of the Codeine Narcotic global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Single-ingredient Codeine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Codeine Narcotic include Taiji, Mallinckrodt, TEVA, Johnson & Johnson, and Medreich, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Codeine Narcotic market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Single-ingredient Codeine
Multi-ingredient Medications
Market segment by Application can be divided into
Narcotic Analgesic
Antitussive
Others
The key market players for global Codeine Narcotic market are listed below:
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Codeine Narcotic product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Codeine Narcotic, with price, sales, revenue and global market share of Codeine Narcotic from 2019 to 2022.
Chapter 3, the Codeine Narcotic competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Codeine Narcotic breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Codeine Narcotic market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Codeine Narcotic.
Chapter 13, 14, and 15, to describe Codeine Narcotic sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Codeine Narcotic Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Codeine Narcotic Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Single-ingredient Codeine
1.2.3 Multi-ingredient Medications
1.3 Market Analysis by Application
1.3.1 Overview: Global Codeine Narcotic Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Narcotic Analgesic
1.3.3 Antitussive
1.3.4 Others
1.4 Global Codeine Narcotic Market Size & Forecast
1.4.1 Global Codeine Narcotic Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Codeine Narcotic Sales in Volume (2017-2028)
1.4.3 Global Codeine Narcotic Price (2017-2028)
1.5 Global Codeine Narcotic Production Capacity Analysis
1.5.1 Global Codeine Narcotic Total Production Capacity (2017-2028)
1.5.2 Global Codeine Narcotic Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Codeine Narcotic Market Drivers
1.6.2 Codeine Narcotic Market Restraints
1.6.3 Codeine Narcotic Trends Analysis
2 Manufacturers Profiles
2.1 Taiji
2.1.1 Taiji Details
2.1.2 Taiji Major Business
2.1.3 Taiji Codeine Narcotic Product and Services
2.1.4 Taiji Codeine Narcotic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Mallinckrodt
2.2.1 Mallinckrodt Details
2.2.2 Mallinckrodt Major Business
2.2.3 Mallinckrodt Codeine Narcotic Product and Services
2.2.4 Mallinckrodt Codeine Narcotic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 TEVA
2.3.1 TEVA Details
2.3.2 TEVA Major Business
2.3.3 TEVA Codeine Narcotic Product and Services
2.3.4 TEVA Codeine Narcotic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business
2.4.3 Johnson & Johnson Codeine Narcotic Product and Services
2.4.4 Johnson & Johnson Codeine Narcotic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Medreich
2.5.1 Medreich Details
2.5.2 Medreich Major Business
2.5.3 Medreich Codeine Narcotic Product and Services
2.5.4 Medreich Codeine Narcotic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Sanofi Aventis
2.6.1 Sanofi Aventis Details
2.6.2 Sanofi Aventis Major Business
2.6.3 Sanofi Aventis Codeine Narcotic Product and Services
2.6.4 Sanofi Aventis Codeine Narcotic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Cipla
2.7.1 Cipla Details
2.7.2 Cipla Major Business
2.7.3 Cipla Codeine Narcotic Product and Services
2.7.4 Cipla Codeine Narcotic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Hikma
2.8.1 Hikma Details
2.8.2 Hikma Major Business
2.8.3 Hikma Codeine Narcotic Product and Services
2.8.4 Hikma Codeine Narcotic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Pharmaceutical Associates
2.9.1 Pharmaceutical Associates Details
2.9.2 Pharmaceutical Associates Major Business
2.9.3 Pharmaceutical Associates Codeine Narcotic Product and Services
2.9.4 Pharmaceutical Associates Codeine Narcotic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Codeine Narcotic Product and Services
2.10.4 Novartis Codeine Narcotic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Apotex
2.11.1 Apotex Details
2.11.2 Apotex Major Business
2.11.3 Apotex Codeine Narcotic Product and Services
2.11.4 Apotex Codeine Narcotic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Mylan
2.12.1 Mylan Details
2.12.2 Mylan Major Business
2.12.3 Mylan Codeine Narcotic Product and Services
2.12.4 Mylan Codeine Narcotic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Aristo Pharma GmbH
2.13.1 Aristo Pharma GmbH Details
2.13.2 Aristo Pharma GmbH Major Business
2.13.3 Aristo Pharma GmbH Codeine Narcotic Product and Services
2.13.4 Aristo Pharma GmbH Codeine Narcotic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Lannett Company
2.14.1 Lannett Company Details
2.14.2 Lannett Company Major Business
2.14.3 Lannett Company Codeine Narcotic Product and Services
2.14.4 Lannett Company Codeine Narcotic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Laboratoire Riva
2.15.1 Laboratoire Riva Details
2.15.2 Laboratoire Riva Major Business
2.15.3 Laboratoire Riva Codeine Narcotic Product and Services
2.15.4 Laboratoire Riva Codeine Narcotic Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Codeine Narcotic Breakdown Data by Manufacturer
3.1 Global Codeine Narcotic Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Codeine Narcotic Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Codeine Narcotic
3.4 Market Concentration Rate
3.4.1 Top 3 Codeine Narcotic Manufacturer Market Share in 2021
3.4.2 Top 6 Codeine Narcotic Manufacturer Market Share in 2021
3.5 Global Codeine Narcotic Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Codeine Narcotic Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Codeine Narcotic Market Size by Region
4.1.1 Global Codeine Narcotic Sales in Volume by Region (2017-2028)
4.1.2 Global Codeine Narcotic Revenue by Region (2017-2028)
4.2 North America Codeine Narcotic Revenue (2017-2028)
4.3 Europe Codeine Narcotic Revenue (2017-2028)
4.4 Asia-Pacific Codeine Narcotic Revenue (2017-2028)
4.5 South America Codeine Narcotic Revenue (2017-2028)
4.6 Middle East and Africa Codeine Narcotic Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Codeine Narcotic Sales in Volume by Type (2017-2028)
5.2 Global Codeine Narcotic Revenue by Type (2017-2028)
5.3 Global Codeine Narcotic Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Codeine Narcotic Sales in Volume by Application (2017-2028)
6.2 Global Codeine Narcotic Revenue by Application (2017-2028)
6.3 Global Codeine Narcotic Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Codeine Narcotic Sales by Type (2017-2028)
7.2 North America Codeine Narcotic Sales by Application (2017-2028)
7.3 North America Codeine Narcotic Market Size by Country
7.3.1 North America Codeine Narcotic Sales in Volume by Country (2017-2028)
7.3.2 North America Codeine Narcotic Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Codeine Narcotic Sales by Type (2017-2028)
8.2 Europe Codeine Narcotic Sales by Application (2017-2028)
8.3 Europe Codeine Narcotic Market Size by Country
8.3.1 Europe Codeine Narcotic Sales in Volume by Country (2017-2028)
8.3.2 Europe Codeine Narcotic Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Codeine Narcotic Sales by Type (2017-2028)
9.2 Asia-Pacific Codeine Narcotic Sales by Application (2017-2028)
9.3 Asia-Pacific Codeine Narcotic Market Size by Region
9.3.1 Asia-Pacific Codeine Narcotic Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Codeine Narcotic Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Codeine Narcotic Sales by Type (2017-2028)
10.2 South America Codeine Narcotic Sales by Application (2017-2028)
10.3 South America Codeine Narcotic Market Size by Country
10.3.1 South America Codeine Narcotic Sales in Volume by Country (2017-2028)
10.3.2 South America Codeine Narcotic Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Codeine Narcotic Sales by Type (2017-2028)
11.2 Middle East & Africa Codeine Narcotic Sales by Application (2017-2028)
11.3 Middle East & Africa Codeine Narcotic Market Size by Country
11.3.1 Middle East & Africa Codeine Narcotic Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Codeine Narcotic Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Codeine Narcotic and Key Manufacturers
12.2 Manufacturing Costs Percentage of Codeine Narcotic
12.3 Codeine Narcotic Production Process
12.4 Codeine Narcotic Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Codeine Narcotic Typical Distributors
13.3 Codeine Narcotic Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---